ScholarIQanswers from OpenAlex
AZ Delta
InstitutionResearch output, impact & collaborations
AZ Delta is a institution indexed in ScholarIQ from OpenAlex.
What is known about AZ Delta?
ScholarIQrecord summary
AZ Delta is a research organisation in Roeselare, BE. OpenAlex records 1,344 works and 36,464 citations for it. 445 researchers list it as their most recent affiliation.
How many works does AZ Delta have?
ScholarIQindexed works
AZ Delta has 1,344 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does AZ Delta have?
ScholarIQcitation count
AZ Delta has 36,464 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at AZ Delta?
ScholarIQresearcher count
AZ Delta has 445 researchers in the ScholarIQ index.
What is the average h-index at AZ Delta?
ScholarIQavg h-index
AZ Delta has an average h-index of 54 in OpenAlex.
What is the OpenAlex record for AZ Delta?
ScholarIQopenalex
The OpenAlex for AZ Delta is on the source record.
Who are the most-cited researchers behind AZ Delta?
ScholarIQtop researchers by citations
What are the most-cited papers on AZ Delta?
ScholarIQmost cited works
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Filip Baert, Maja Noman, Séverine Vermeire, Gert Van Assche, Geert D' Haens, An Carbonez, Paul Rutgeerts
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease
Julián Panés, Julián Panés, Damián García-Olmo, Gert Van Assche, Jean Frederic Colombel, Walter Reinisch, Daniel C. Baumgart, Axel Dignaß, Maria Nachury, Marc Ferrante, Lili Kazemi-Shirazi, Jean Charles Grimaud, Fernando de la Portilla, Eran Goldin, M Richard, Mary Carmen Díez, Ignacio Tagarro, Anne Leselbaum, Silvio Danese, Julián Panés, Julián Panés, Daniel C. Baumgart, Jean F. Colombel, Silvio Danese, Gert Van Assche, Walter Reinisch, Damián García-Olmo, Anton Stift, Jörg Tschmelitsch, Karl Mrak, Herbert Tilg, Irmgard Kroberger, André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier Pérez Gisbert, Rosana Palasí, Carlos Taxonera Samsó, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Daniel Carpio López, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, F. Xavier González Argenté, C. Martínez Pastor, Héctor Guadalajara
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
William J. Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi, Xiaopan Yao, Jingjing Chen, Maria Rosario, Siddharth Bhatia, Krisztina Kisfalvi, Geert D’Haens, Séverine Vermeire
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, Anthony de Buck van Overstraeten, Thomas Billiet, Filip Baert, Albert Wolthuis, Gert Van Assche, Maja Noman, Ilse Hoffman, André D’Hoore, Ann Gils, Paul Rutgeerts, Marc Ferrante
How much of the research on AZ Delta is open access?
ScholarIQopen access share
100%OPEN ACCESS